Phase 3 Social Anxiety Disorder Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Social Anxiety Disorder (SAD)
VistaGen Therapeutics, Inc.236 enrolled26 locationsNCT06615557
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Social Anxiety Disorder (SAD)
Vanda Pharmaceuticals500 enrolled29 locationsNCT07221578
Recruiting
Phase 3
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
AnxietySocial Anxiety DisorderADHD+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.308 enrolled47 locationsNCT06973577
Not Yet Recruiting
Phase 3
PAPAYA: Pharmacologically-Assisted Psychotherapy for social Anxiety in Young people with Autism
Autism Spectrum DisorderSocial Anxiety Disorder
Orygen156 enrolled1 locationACTRN12624001474549
Completed
Phase 2Phase 3
The use of tiagabine and gabapentin in the treatment of social anxiety disorder in 8 patients
Subjects with social anxiety disorder
Maria Urbano, M.D.8 enrolled1 locationACTRN12609000091202
Completed
Phase 3
Effects of Oxytocin on Amygdala Response to Threat in Generalised Social Anxiety Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study
Generalised Social Anxiety Disorder
School of Psychology, Psychiatry and Psychological Medicine, Monash University40 enrolled1 locationACTRN12607000141448